Rabbit Syndrome and Newer Antipsychotics
Author Information
Author(s): Catena Dell'Osso Mario, Fagiolini Andrea, Ducci Francesca, Masalehdan Azadeh, Ciapparelli Antonio, Frank Ellen
Primary Institution: University of Florence, University of Pisa, University of Pittsburgh School of Medicine, National Institutes of Health
Hypothesis
What is the risk of rabbit syndrome associated with newer atypical antipsychotics?
Conclusion
Rabbit syndrome has been documented in patients treated with newer antipsychotics, particularly risperidone, and can be effectively treated with anticholinergic agents.
Supporting Evidence
- Eleven cases of rabbit syndrome have been documented since the implementation of newer antipsychotics.
- Rabbit syndrome symptoms can improve quickly after reintroducing the medication that caused them.
- Rabbit syndrome is characterized by fine, rapid, rhythmic movements of the mouth.
Takeaway
Rabbit syndrome is a movement disorder that can happen when people take certain medications for mental health, and it can be treated with other medicines.
Methodology
The study reviewed literature and a case study related to rabbit syndrome and newer antipsychotics.
Limitations
The study is limited by the small number of documented cases and the need for further research.
Participant Demographics
The documented cases primarily involved middle-aged and elderly patients, with a higher prevalence in women.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website